Berlin Launches Academy

WEST BERLIN—The forging of stronger ties among researchers, and between academia and industry, are two important goals of this city’s new Academy of Science (see THE SCIENTIST, March 9, p. 5). The academy, after opening ceremonies later this week, will begin work on a research agenda that will span the natural and medical sciences as well as technology assessment. The first six projects, chosen from 39 proposals and each expected to last three years, will cover automation and the


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WEST BERLIN—The forging of stronger ties among researchers, and between academia and industry, are two important goals of this city’s new Academy of Science (see THE SCIENTIST, March 9, p. 5).

The academy, after opening ceremonies later this week, will begin work on a research agenda that will span the natural and medical sciences as well as technology assessment. The first six projects, chosen from 39 proposals and each expected to last three years, will cover automation and the future workplace, solar energy, environmental standards, the role of innovation in society, gerontology and the exodus of scientists from Berlin during the Third Reich

The Berlin Scnate has promised $4.2 million annually for support of operations and two of the six initial projects. The academy hopes to obtain industrial funding for the other efforts, which will be pursued as resources become available.

Horst Albach, professor of business administration at the universities ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide